Diagnosis Codes in MS-DRG 948 - Signs And Symptoms Without MCC

The Medicare Severity Diagnosis-Related Group (MS-DRG) is a patient classification system used to categorize hospital cases based on clinical similarity and expected resource use. MS-DRGs organize all possible principal diagnoses into mutually exclusive groups known as Major Diagnostic Categories (MDCs), which help determine reimbursement under the Medicare Inpatient Prospective Payment System.

This section lists the diagnosis codes included in MS-DRG V42.0: Signs and Symptoms without MCC from October 1, 2024, through September 30, 2025.

  1. E07.8 - Other specified disorders of thyroid
  2. E79 - Disorders of purine and pyrimidine metabolism
  3. G89 - Pain, not elsewhere classified
  4. G89.1 - Acute pain, not elsewhere classified
  5. G93.3 - Postviral and related fatigue syndromes
  6. P09 - Abnormal findings on neonatal screening
  7. R18 - Ascites
  8. R23 - Other skin changes
  9. R41 - Other symptoms and signs involving cognitive functions
  10. R41.8 - Other symptoms and signs involving cognitive functio
  11. R45.8 - Other symptoms and signs involving emotional state
  12. R53 - Malaise and fatigue
  13. R53.8 - Other malaise and fatigue
  14. R60 - Edema, not elsewhere classified
  15. R68 - Other general symptoms and signs
  16. R68.1 - Nonspecific symptoms peculiar to infancy
  17. R68.8 - Other general symptoms and signs
  18. R70 - Elevated erythrocyte sedimentation rate and abnormalit
  19. R74 - Abnormal serum enzyme levels
  20. R74.0 - Nonspecific elevation of levels of transaminase and
  21. R77 - Other abnormalities of plasma proteins
  22. R78 - Findings of drugs and other substances, not normally f
  23. R78.7 - Finding of abnormal level of heavy metals in blood
  24. R78.8 - Finding of other specified substances, not normally
  25. R79 - Other abnormal findings of blood chemistry
  26. R79.8 - Other specified abnormal findings of blood chemistry
  27. R82 - Other and unspecified abnormal findings in urine
  28. R84 - Abnormal findings in specimens from respiratory organs
  29. R85 - Abnormal findings in specimens from digestive organs a
  30. R85.6 - Abnormal cytological findings in specimens from dige
  31. R85.8 - Other abnormal findings in specimens from digestive
  32. R87 - Abnormal findings in specimens from female genital org
  33. R87.6 - Abnormal cytological findings in specimens from fema
  34. R87.61 - Abnormal cytological findings in specimens from cer
  35. R87.62 - Abnormal cytological findings in specimens from vag
  36. R87.8 - Other abnormal findings in specimens from female gen
  37. R88 - Abnormal findings in other body fluids and substances
  38. R89 - Abnormal findings in specimens from other organs, syst
  39. R90.8 - Other abnormal findings on diagnostic imaging of cen
  40. R93 - Abnormal findings on diagnostic imaging of other body
  41. R93.8 - Abnormal findings on diagnostic imaging of other spe
  42. R97 - Abnormal tumor markers
  43. R97.2 - Elevated prostate specific antigen [PSA]
  44. Z17.2 - Progesterone receptor status
  • -

    • R52 - Pain, unspecified

    • R64 - Cachexia

  • E07.8 - Other specified disorders of thyroid

    • E07.81 - Sick-euthyroid syndrome

  • E79 - Disorders of purine and pyrimidine metabolism

    • E79.0 - Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

  • G89 - Pain, not elsewhere classified

    • G89.3 - Neoplasm related pain (acute) (chronic)

  • G89.1 - Acute pain, not elsewhere classified

    • G89.11 - Acute pain due to trauma

    • G89.12 - Acute post-thoracotomy pain

    • G89.18 - Other acute postprocedural pain

  • P09 - Abnormal findings on neonatal screening

    • P09.1 - Abnormal findings on neonatal screening for inborn errors of metabolism

    • P09.2 - Abnormal findings on neonatal screening for congenital endocrine disease

    • P09.3 - Abnormal findings on neonatal screening for congenital hematologic disorders

    • P09.4 - Abnormal findings on neonatal screening for cystic fibrosis

    • P09.5 - Abnormal findings on neonatal screening for critical congenital heart disease

    • P09.6 - Abnormal findings on neonatal screening for neonatal hearing loss

    • P09.8 - Other abnormal findings on neonatal screening

    • P09.9 - Abnormal findings on neonatal screening, unspecified

  • R18 - Ascites

  • R23 - Other skin changes

  • R41 - Other symptoms and signs involving cognitive functions and awareness

    • R41.0 - Disorientation, unspecified

    • R41.1 - Anterograde amnesia

    • R41.2 - Retrograde amnesia

    • R41.3 - Other amnesia

    • R41.9 - Unspecified symptoms and signs involving cognitive functions and awareness

  • R41.8 - Other symptoms and signs involving cognitive functions and awareness

    • R41.82 - Altered mental status, unspecified

  • R45.8 - Other symptoms and signs involving emotional state

    • R45.83 - Excessive crying of child, adolescent or adult

    • R45.84 - Anhedonia

  • R53 - Malaise and fatigue

    • R53.0 - Neoplastic (malignant) related fatigue

    • R53.1 - Weakness

    • R53.2 - Functional quadriplegia

  • R53.8 - Other malaise and fatigue

  • R60 - Edema, not elsewhere classified

    • R60.0 - Localized edema

    • R60.1 - Generalized edema

    • R60.9 - Edema, unspecified

  • R68 - Other general symptoms and signs

    • R68.0 - Hypothermia, not associated with low environmental temperature

  • R68.1 - Nonspecific symptoms peculiar to infancy

    • R68.11 - Excessive crying of infant (baby)

    • R68.12 - Fussy infant (baby)

  • R68.8 - Other general symptoms and signs

    • R68.81 - Early satiety

    • R68.83 - Chills (without fever)

    • R68.89 - Other general symptoms and signs

  • R70 - Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

    • R70.0 - Elevated erythrocyte sedimentation rate

    • R70.1 - Abnormal plasma viscosity

  • R74 - Abnormal serum enzyme levels

    • R74.8 - Abnormal levels of other serum enzymes

    • R74.9 - Abnormal serum enzyme level, unspecified

  • R74.0 - Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

    • R74.01 - Elevation of levels of liver transaminase levels

    • R74.02 - Elevation of levels of lactic acid dehydrogenase [LDH]

  • R77 - Other abnormalities of plasma proteins

    • R77.0 - Abnormality of albumin

    • R77.1 - Abnormality of globulin

    • R77.2 - Abnormality of alphafetoprotein

    • R77.8 - Other specified abnormalities of plasma proteins

    • R77.9 - Abnormality of plasma protein, unspecified

  • R78 - Findings of drugs and other substances, not normally found in blood

    • R78.1 - Finding of opiate drug in blood

    • R78.2 - Finding of cocaine in blood

    • R78.3 - Finding of hallucinogen in blood

    • R78.4 - Finding of other drugs of addictive potential in blood

    • R78.5 - Finding of other psychotropic drug in blood

    • R78.6 - Finding of steroid agent in blood

    • R78.9 - Finding of unspecified substance, not normally found in blood

  • R78.7 - Finding of abnormal level of heavy metals in blood

    • R78.71 - Abnormal lead level in blood

    • R78.79 - Finding of abnormal level of heavy metals in blood

  • R78.8 - Finding of other specified substances, not normally found in blood

    • R78.89 - Finding of other specified substances, not normally found in blood

  • R79 - Other abnormal findings of blood chemistry

    • R79.0 - Abnormal level of blood mineral

    • R79.1 - Abnormal coagulation profile

    • R79.9 - Abnormal finding of blood chemistry, unspecified

  • R79.8 - Other specified abnormal findings of blood chemistry

    • R79.81 - Abnormal blood-gas level

    • R79.82 - Elevated C-reactive protein (CRP)

    • R79.83 - Abnormal findings of blood amino-acid level

    • R79.89 - Other specified abnormal findings of blood chemistry

  • R82 - Other and unspecified abnormal findings in urine

  • R84 - Abnormal findings in specimens from respiratory organs and thorax

    • R84.0 - Abnormal level of enzymes in specimens from respiratory organs and thorax

    • R84.1 - Abnormal level of hormones in specimens from respiratory organs and thorax

    • R84.2 - Abnormal level of other drugs, medicaments and biological substances in specimens from respiratory organs and thorax

    • R84.3 - Abnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax

    • R84.4 - Abnormal immunological findings in specimens from respiratory organs and thorax

    • R84.5 - Abnormal microbiological findings in specimens from respiratory organs and thorax

    • R84.6 - Abnormal cytological findings in specimens from respiratory organs and thorax

    • R84.7 - Abnormal histological findings in specimens from respiratory organs and thorax

    • R84.8 - Other abnormal findings in specimens from respiratory organs and thorax

    • R84.9 - Unspecified abnormal finding in specimens from respiratory organs and thorax

  • R85 - Abnormal findings in specimens from digestive organs and abdominal cavity

    • R85.0 - Abnormal level of enzymes in specimens from digestive organs and abdominal cavity

    • R85.1 - Abnormal level of hormones in specimens from digestive organs and abdominal cavity

    • R85.2 - Abnormal level of other drugs, medicaments and biological substances in specimens from digestive organs and abdominal cavity

    • R85.3 - Abnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity

    • R85.4 - Abnormal immunological findings in specimens from digestive organs and abdominal cavity

    • R85.5 - Abnormal microbiological findings in specimens from digestive organs and abdominal cavity

    • R85.7 - Abnormal histological findings in specimens from digestive organs and abdominal cavity

    • R85.9 - Unspecified abnormal finding in specimens from digestive organs and abdominal cavity

  • R85.6 - Abnormal cytological findings in specimens from digestive organs and abdominal cavity

    • R85.69 - Abnormal cytological findings in specimens from other digestive organs and abdominal cavity

  • R85.8 - Other abnormal findings in specimens from digestive organs and abdominal cavity

    • R85.89 - Other abnormal findings in specimens from digestive organs and abdominal cavity

  • R87 - Abnormal findings in specimens from female genital organs

    • R87.0 - Abnormal level of enzymes in specimens from female genital organs

    • R87.1 - Abnormal level of hormones in specimens from female genital organs

    • R87.2 - Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs

    • R87.3 - Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs

    • R87.4 - Abnormal immunological findings in specimens from female genital organs

    • R87.5 - Abnormal microbiological findings in specimens from female genital organs

    • R87.7 - Abnormal histological findings in specimens from female genital organs

    • R87.9 - Unspecified abnormal finding in specimens from female genital organs

  • R87.6 - Abnormal cytological findings in specimens from female genital organs

    • R87.69 - Abnormal cytological findings in specimens from other female genital organs

  • R87.61 - Abnormal cytological findings in specimens from cervix uteri

    • R87.618 - Other abnormal cytological findings on specimens from cervix uteri

    • R87.619 - Unspecified abnormal cytological findings in specimens from cervix uteri

  • R87.62 - Abnormal cytological findings in specimens from vagina

    • R87.629 - Unspecified abnormal cytological findings in specimens from vagina

  • R87.8 - Other abnormal findings in specimens from female genital organs

    • R87.89 - Other abnormal findings in specimens from female genital organs

  • R88 - Abnormal findings in other body fluids and substances

    • R88.0 - Cloudy (hemodialysis) (peritoneal) dialysis effluent

    • R88.8 - Abnormal findings in other body fluids and substances

  • R89 - Abnormal findings in specimens from other organs, systems and tissues

    • R89.0 - Abnormal level of enzymes in specimens from other organs, systems and tissues

    • R89.1 - Abnormal level of hormones in specimens from other organs, systems and tissues

    • R89.2 - Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues

    • R89.3 - Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues

    • R89.4 - Abnormal immunological findings in specimens from other organs, systems and tissues

    • R89.5 - Abnormal microbiological findings in specimens from other organs, systems and tissues

    • R89.6 - Abnormal cytological findings in specimens from other organs, systems and tissues

    • R89.7 - Abnormal histological findings in specimens from other organs, systems and tissues

    • R89.8 - Other abnormal findings in specimens from other organs, systems and tissues

  • R90.8 - Other abnormal findings on diagnostic imaging of central nervous system

    • R90.89 - Other abnormal findings on diagnostic imaging of central nervous system

  • R93 - Abnormal findings on diagnostic imaging of other body structures

    • R93.9 - Diagnostic imaging inconclusive due to excess body fat of patient

  • R93.8 - Abnormal findings on diagnostic imaging of other specified body structures

    • R93.89 - Abnormal findings on diagnostic imaging of other specified body structures

  • R97 - Abnormal tumor markers

    • R97.0 - Elevated carcinoembryonic antigen [CEA]

    • R97.1 - Elevated cancer antigen 125 [CA 125]

    • R97.8 - Other abnormal tumor markers

  • R97.2 - Elevated prostate specific antigen [PSA]

    • R97.20 - Elevated prostate specific antigen [PSA]

    • R97.21 - Rising PSA following treatment for malignant neoplasm of prostate

  • Z17.2 - Progesterone receptor status

    • Z17.21 - Progesterone receptor positive status

    • Z17.22 - Progesterone receptor negative status